In eukaryotic cells, the plasma membrane consists of inner and outer leaflets between which phospholipids are asymmetrically distributed. For example, phosphatidylserine (PtdSer) and phosphatidylethanolamine (PtdEtn) are strictly confined to the inner leaflets. This asymmetrical distribution is maintained by flippases ([@r1], [@r2]), and we recently identified the P4-type ATPases ATP11A and ATP11C as the flippases that translocate PtdSer and PtdEtn from the outer leaflet to the inner leaflet in the plasma membrane ([@r3]).

Apoptotic cells or activated platelets expose PtdSer through the activities of scramblases, which are activated either by caspase or Ca^2+^ ([@r4]). Transmembrane protein 16F (TMEM16F), a member of the TMEM16 family, is a Ca^2+^-dependent phospholipid scramblase ([@r5]) that mediates PtdSer exposure in activated platelets during blood clotting and regulates hydroxyapatite release from osteoblasts during bone mineralization ([@r6], [@r7]). Similar to TMEM16A, which functions as a Ca^2+^-dependent Cl^−^ channel ([@r8]), Ca^2+^ binds directly to TMEM16F and presumably induces conformational changes ([@r9]), resulting in activation of the scrambling reaction. A recent theoretical analysis ([@r10]) based on the tertiary structure of the fungal ortholog of TMEM16 ([@r11]), along with mutational analysis of mouse TMEM16F (mTMEM16F) ([@r12]), suggests a "stepping-stone" model for TMEM16F-mediated phospholipid scrambling, as described in more detail later.

The biophysical features of TMEM16F-mediated lipid scrambling have not been well characterized because the purification of intact TMEM16F is difficult. Moreover, membrane bilayers with asymmetrically distributed phospholipids are challenging to construct, with a few exceptions ([@r13][@r14]--[@r15]). We recently developed microarrays containing membrane bilayers to study membrane transporters at the single-molecule level ([@r16][@r17]--[@r18]). Therefore, in this study, we further developed a microarray system containing asymmetrical membrane bilayers with fluorescently labeled phospholipids in only one leaflet. Additionally, we established a cell line that stably overexpressed mTMEM16F and succeeded in purifying this protein to near homogeneity. By introducing the purified mTMEM16F into the microsystem, we analyzed the functional dynamics of mTMEM16F-mediated phospholipid scrambling at the single-molecule level and found that the scrambling system was remarkably efficient.

Results {#s1}
=======

Purification of mTMEM16F. {#s2}
-------------------------

mTMEM16F consists of 10 transmembrane segments with cytoplasmic N- and C-terminal tails and a Ca^2+^-binding site located between transmembrane segments 6, 7, and 8 ([@r9], [@r11]) ([Fig. 1*A*](#fig01){ref-type="fig"}). In contrast to transient large-scale production of mTMEM16A ([@r19]), the transient overexpression of mTMEM16F in 293T cells caused protein aggregation. To circumvent this, we established a Ba/F3 stable transformant that showed high expression of mTMEM16F in the plasma membrane; that is, Ba/F3 cells were transfected with the expression plasmid carrying Flag-tagged *mTMEM16F* cDNA under the elongation factor-1α promoter and puromycin resistance gene, and stable transformants were selected in the presence of 2 μg/mL puromycin. A monoclonal antibody (mAb) against the fifth extracellular region of mTMEM16F (amino acids 745--825; [Fig. 1*A*](#fig01){ref-type="fig"}) recognized cells expressing mTMEM16F. Approximately 1.7% of the population of the transformants expressing high levels of mTMEM16F was sorted by flow cytometry and expanded in the presence of 4 μg/mL puromycin. This procedure (i.e., sorting by flow cytometry and expansion in the presence of increasing concentrations of puromycin) was repeated, resulting in a gradual increase in the expression level of mTMEM16F ([Fig. 1*B*](#fig01){ref-type="fig"}). After the ninth sorting, cells that expressed mTMEM16F at a level more than 15-fold that of the original cells were subjected to limiting dilution to obtain a clone (S9-12) showing strong expression of mTMEM16F.

![Transformants overexpressing TMEM16F and purified TMEM16F. (*A*) Schematic structure of the mTMEM16F structure. The fifth extracellular region used as an antigen to prepare mAbs against mTMEM16F is indicated in red. The numbers indicate the positions of the first and last amino acids of the fifth extracellular region. (*B*) Establishment of a Ba/F3 transformant overexpressing mTMEM16F by fluorescence-activated cell sorting (FACS). (*Top*) Original Ba/F3 transformants expressing mTMEM16F were stained with anti-mTMEM16F mAbs, and cells in the boxed area were collected using a FACSAria II. (*Bottom*) Cells sorted twice (S2) or eight times (S8) were stained with anti-mTMEM16F mAbs, and their staining profiles are shown, together with those of the Ba/F3 cells transformed by the empty vector. (*C* and *D*) Biochemical characterization of the purified mTMEM16F. The purified mTMEM16F was analyzed by SDS/PAGE and BN/PAGE (*C*) and gel filtration (*D*) using 1.5 μg, 2.9 μg, and 0.5 μg of protein, respectively. Proteins in SDS/PAGE and BN/PAGE were stained with Coomassie Brilliant Blue, whereas proteins in gel filtration were detected by intrinsic tryptophan fluorescence. Precision Plus Protein Standards (Bio-Rad) and NativeMark Unstained Protein Standards (Thermo Fisher Scientific) were used as molecular weight standards for SDS/PAGE and BN/PAGE, respectively, and their molecular weights are shown on the left. In gel filtration, thyroglobulin (669 kDa), ferritin (440 kDa), aldolase (158 kDa), and ovalbumin (44 kDa) were analyzed. AU, arbitrary unit.](pnas.1717956115fig01){#fig01}

Flag-tagged mTMEM16F was purified from the solubilized membrane fraction of S9-12 transformants by affinity chromatography with anti-Flag mAbs. Briefly, S9-12 cells were subjected to large-scale culture, and the membrane fraction was prepared by ultracentrifugation. After solubilizing the membrane fraction with 1% lauryl maltose neopentyl glycol (LMNG), Flag-tagged mTMEM16F was bound to the anti-Flag mAb and eluted with a linear gradient of LiCl, which strongly improved the purification efficiency compared with conventional stepwise elution with a Flag peptide. Because LMNG bound to proteins is not easily released from the protein ([@r20]), the purified mTMEM16F was subjected to the gradient-based detergent removal (GraDeR) procedure ([@r21]) to remove the excess LMNG, which was expected to enhance the integration of mTMEM16F into lipid bilayers. Overall, about 150 μg of protein was obtained from a 5-L culture of S9-12.

The final preparation of mTMEM16F was nearly homogeneous in SDS and Blue-native/polyacrylamide gel electrophoresis (BN/PAGE; [Fig. 1*C*](#fig01){ref-type="fig"}). The apparent *M*~r~ of TMEM16F in SDS/PAGE was 140 kDa, whereas that in BN/PAGE was 520 kDa. The mTMEM16F harbored six *N*-glycosylation sites, which may explain the apparent differences between the *M*~r~ in SDS/PAGE and the calculated *M*~r~ (108,413.1 Da). Because the apparent size of membrane proteins in BN/PAGE was 1.8-fold larger than the actual size ([@r22]), mTMEM16F in the native form was a dimer, consistent with previous results obtained by chemical cross-linking ([@r23]). The minor band observed at around 280 kDa in SDS/PAGE was likely to be a dimer that persisted under the mild conditions used for SDS/PAGE (i.e., no heating of the sample in SDS sample buffer). Gel filtration analysis of the purified TMEM16F protein ([Fig. 1*D*](#fig01){ref-type="fig"}) indicated that the protein was of high monodispersity, with an apparent *M*~r~ of ∼500 kDa. Although the subunit structure of membrane proteins cannot be determined by gel filtration ([@r24]), the similar size obtained by BN/PAGE supported that the TMEM16F protein existed as a homodimer.

Formation of Lipid Membranes on Microarrays. {#s3}
--------------------------------------------

Microarrays with more than 10,000 microchambers (diameter: 2.4--8.2 μm, height: 0.5 μm) were fabricated by soft lithography ([@r16]) on a hydrophilic glass substrate coated with carbon-fluorine polymer (CYTOP; Asahi-Glass) ([Fig. 2*A*](#fig02){ref-type="fig"}). The experimental system consisted of glass substrates with microarrays, a spacer sheet, and a glass block with an access port for sample injection ([Fig. S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)). To construct phospholipid membranes, the microchambers were first filled with an aqueous solution containing Alexa Fluor 405, which was used to monitor the integrity of lipid bilayers during experiments ([Fig. S2*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)). A chloroform solution containing 0.3 mg/mL 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) with the indicated amount of acyl-chain--modified fluorescent phospholipids \[i.e., 1.0 μg/mL TopFluor-TMR-PS (serine), TopFluor-TMR-PC (choline), and TopFluor-TMR-PE (ethanolamine)\] was then infused via the access port. At these concentrations, water-in-oil droplets formed and deposited a lipid monolayer over orifices of microchambers ([Fig. S2*B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)). Chloroform is the most suitable organic solvent for the formation of a thin lipid membrane on microarrays in a high-throughput manner ([@r15][@r16]--[@r17]). Finally, a second aqueous solution was infused to form another lipid monolayer at the interface with the chloroform solution, which was then deposited over the entire surface of the device ([Fig. S2*B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)). Thus, bilayers were formed over microchambers containing Alexa Fluor 405, whereas monolayers were formed elsewhere ([Fig. 2*A*](#fig02){ref-type="fig"}). Three-dimensional measurements indicated that the fluorescent intensity in microchambers was obviously higher than that on the surface of the polymer ([Fig. 2*C*](#fig02){ref-type="fig"}), confirming the membrane geometry in the microarray and suggesting that the outer membrane layers over microchambers, but not the inner layers, were contiguous with the monolayer in other parts of the device ([Fig. 2*A*](#fig02){ref-type="fig"}).

![Microarray assay system for phospholipid scramblase. (*A*) Microchambers fabricated with CYTOP on a glass substrate. Each microchamber was filled with an aqueous solution (purple) and covered with phospholipid bilayers of POPC (gray) and fluorescent phospholipids (red). All other areas were covered by a monolayer of the same phospholipids, the fatty acids of which faced the hydrophobic CYTOP polymer. This monolayer was contiguous with the upper leaflets of bilayers deposited at the top of microchambers. (*B*) Procedures. (*i*) Membrane bilayers formed over microchambers were exposed for a few seconds to a laser to (*ii*) photobleach fluorescently labeled phospholipids (red). (*iii*) Fluorescent lipids diffused into the bilayer from the surrounding area, but were then restricted to the outer layer. (*C*) Confocal fluorescence images of microarrays. (*Left*) Maximum intensity projection (top) and cross-sectional (side) views of TopFluor-TMR-PS (red) before and after photobleaching are shown. (*Right*) Intensity profile of the fluorescence along the dashed lines in the top view before (red) and after (gray) photobleaching is shown. AU, arbitrary unit.](pnas.1717956115fig02){#fig02}

To confirm the lamellarity of the membrane, passive transport assays were conducted using α-hemolysin, a toxic membrane protein that specifically binds to unilamellar lipid-bilayer membranes (thickness of ∼4 nm) and forms transmembrane nanopores (diameter: 1--2 nm) ([@r25]). For this assay, microchambers encapsulating Alexa Fluor 488 ([@r16], [@r26]) were treated with α-hemolysin ([Fig. S3*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)). The rapid decay of the fluorescent intensity indicated ([Fig. S3*B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)) that Alexa Fluor 488 was diffused through α-hemolysin pores, confirming that the lipid membranes on the microchambers were unilamellar bilayers.

Formation of Asymmetrical Phospholipid Distributions. {#s4}
-----------------------------------------------------

The fluorescence of phospholipids labeled with TopFluor-TMR in bilayer membranes over microchambers was photobleached to establish the asymmetrical distribution of the phospholipids by exposure to a high-energy laser at λ = 561 nm for a few seconds. As shown in [Fig. 2 *B* and *C*](#fig02){ref-type="fig"}, the fluorescence in microchambers gradually recovered within several hundred seconds to the same level as on the surrounding surfaces, confirming that the membrane over the microchambers was contiguous with the monolayer in other parts of the device ([Fig. 2*A*](#fig02){ref-type="fig"}). This lateral diffusion of phospholipids was temperature-dependent ([Fig. S4](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)), with a diffusion coefficient of ∼1.0 μm^2^⋅s^−1^ at 25 °C; this value was comparable to that for lateral phospholipid diffusion in planar membranes ([@r27]). Notably, the fluorescence recovered over microchambers did not exceed that on surrounding surfaces ([Fig. 2*C*](#fig02){ref-type="fig"}), indicating that vertical translocation of phospholipids between the two layers of the membrane did not occur during measurement or was very slow, as also observed in plasma membranes ([@r28]). In addition, this result suggested that photobleaching generated an asymmetrical membrane bilayer in which unbleached fluorescent phospholipids were present only in the upper layer. Hence, we concluded that this experimental system was suitable to investigate scramblase activity at the single-molecule level, and that the fluorescent intensity in the microchamber would increase upon phospholipid scrambling.

Phospholipid Scrambling Using mTMEM16F. {#s5}
---------------------------------------

Because membrane proteins can be integrated as functional proteins into membrane bilayers on microarrays under detergent-free conditions ([@r29]), the purified mTMEM16F was diluted in Ca^2+^- and detergent-free buffer and was injected into a microarray that had been laser-photobleached ([Fig. 3*A*](#fig03){ref-type="fig"}). The microsystem was then left to stand for 30 min at room temperature to integrate the protein into membrane bilayers.

![Phospholipid scrambling by a single TMEM16F molecule. (*A*) TMEM16F was incorporated into the asymmetrical membrane bilayers with fluorescent phospholipids (red). Addition of CaCl~2~ initiated phospholipid scrambling, followed by lateral diffusion of unbleached phospholipids from surrounding areas, increasing the fluorescence intensity in microchambers. (*B*) Purified TMEM16F was loaded at 3.4 μg/mL, and scrambling was initiated with 100 μM CaCl~2~. Subsequently, the asymmetrical membrane bilayers were again formed by laser irradiation, and the scambling was assayed by injecting 100 μM CaCl~2~ in the presence of 1 μM EGCg. Maximum intensity projections of confocal images of TopFluor-TMR-PS (red) obtained from the same microchambers before (*Top*) and after addition of 100 μM CaCl~2~ (*Middle*) or 100 μM CaCl~2~ + 1 μM EGCg (*Bottom*) are shown. (Scale bars: 5 μm.) AU, arbitrary unit. (*C*) Time course of TMEM16F-mediated phospholipid scrambling. Lipid bilayers with (red) or without (gray) TMEM16F were treated with 100 μM CaCl~2~ (black arrowheads), and fluorescence from TopFluor-TMR-PS was followed over time. Subsequently, the microchambers were reexposed for a few seconds to a laser at time points marked in orange, with (*Bottom*) or without (*Top*) prior injection of 1 μM EGCg (red arrowhead). (*D*) Microarrays with fluorescent TopFluor-TMR-PS in the outer layer were loaded with 0.7, 3.4, or 6.3 μg/mL TMEM16F in buffer containing 100 μM CaCl~2~. The percentage of chambers with scramblase activity was plotted as orange circles, with SDs as error bars. The black line is a linear regression. (*E*) Percentage of chambers with scramblase activity against the membrane area (*S*). Microarrays with TopFluor-TMR-PS were loaded with 3.4 μg/mL TMEM16F in buffer containing 100 μM CaCl~2~. The black line is the linear regression. (*F*) Percentage of microchambers with scramblase activity against the concentration of Ca^2+^ or inhibitors. Microarrays with TopFluor-TMR-PS were loaded with 3.4 μg/mL TMEM16F in a buffer containing the indicated concentrations of CaCl~2~ and inhibitors \[EGCg and tannic acid (TA)\]. (*G*) Percentage of chambers with scramblase activity against fluorescence substrates: TopFluor-TMR-PS (red), TopFluor-TMR-PC (light red), or TopFluor-TMR-PE (pink). Microarrays were loaded with 3.4 μg/mL TMEM16F in buffer containing 100 μM CaCl~2~.](pnas.1717956115fig03){#fig03}

We postulated that in the artificially reconstituted system, TMEM16F would be integrated into membrane bilayers with random topology in one functional enzyme per microchamber at low-protein concentrations. To confirm this, Alexa Fluor 555-labeled anti-FLAG antibodies were infused into the microsystem to visualize C-terminally Flag-tagged TMEM16F in membrane bilayers ([Fig. S5](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)). In this setup, only TMEM16F molecules outwardly orienting the Flag-tag, for which the Ca^2+^ binding site also showed the same topology, were fluorescently labeled. Observation by total internal reflection fluorescence microscopy (TIRFM) indicated that the fluorescence signals of Alexa Fluor 555 exhibited single-step photobleaching ([Fig. S5*B*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)), confirming that individual Alexa Fluor 555 signals corresponded to single TMEM16F molecules. Next, we counted the number of integrated molecules and found that microchambers loaded with 3.4 μg/mL TMEM16F contained an average of 6 × 10^−3^ molecules (i.e., a single molecule of TMEM16F was integrated into the membrane bilayer of 0.60% of microchambers; [Fig. S5*C*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)).

For the scrambling assay, 100 μM Ca^2+^ was infused into the microarrays to activate the phospholipid scrambling of TMEM16F. In this setup, only TMEM16F molecules outwardly orienting the Ca^2+^ binding site were activated by Ca^2+^ infusion. The fluorescent intensity of the bilayer membrane gradually increased upon Ca^2+^ infusion ([Fig. 3 *B* and *C*](#fig03){ref-type="fig"}) in 0.58% of microchambers loaded with 3.4 μg/mL TMEM16F ([Fig. 3*D*](#fig03){ref-type="fig"}), which coincided with the fraction of microchambers containing a single molecule of TMEM16F ([Fig. S5*C*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)). The percentage of microchambers showing a positive response increased in proportion to the concentration of TMEM16F loaded between 0.7 and 6.3 μg/mL ([Fig. 3*D*](#fig03){ref-type="fig"} and [Fig. S6](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)) and in proportion to the size of the microchamber (and hence the membrane area; [Fig. 3*E*](#fig03){ref-type="fig"} and [Fig. S7](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)). These properties are typical of a single-molecule digital assay ([@r16], [@r30], [@r31]) and suggested that a single functional unit mediated the increase in fluorescence in each microchamber.

The fluorescent intensity at microchambers loaded with TMEM16F gradually increased to reach the original intensity level before photobleaching ([Fig. 3*C*](#fig03){ref-type="fig"}), irrespective of the phospholipid composition of the membranes ([Figs. S8](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental) and [S9](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)). This suggested that the fluorescent phospholipids were translocated from the outer layer to the inner layer, which was followed by lateral diffusion from the surrounding monolayer. This increase in fluorescence was not observed in microchambers not loaded with TMEM16F or in those loaded with the purified TMEM16A, a Ca^2+^-dependent Cl^−^ channel ([@r19]) ([Fig. S10](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)).

TMEM16F-mediated phospholipid scrambling is known to be Ca^2+^-dependent, nonspecific for phospholipids, and inhibited by tannic acid or epigallocatechin gallate (EGCg) ([@r23]). Accordingly, only a very small percentage (0.09%) of TMEM16F-loaded microchambers gained fluorescence in the absence of Ca^2+^, and this percentage increased to 0.6% after supplementation with 100 μM Ca^2+^ ([Fig. 3*F*](#fig03){ref-type="fig"}). In addition, increased fluorescence was observed at similar efficiencies for various fluorescence substrates (i.e., TopFluor-TMR-PS, TopFluor-TMR-PC, TopFluor-TMR-PE) ([Fig. 3*G*](#fig03){ref-type="fig"}), and this increase was fully blocked with 1.0 μM tannic acid or EGCg ([Fig. 3*F*](#fig03){ref-type="fig"}). Collectively, these results strongly indicated that TMEM16F supported the translocation of fluorescent phospholipids between membrane bilayers at the single-molecule level. Notably, when loaded microchambers that had already gained more fluorescence than the surrounding area were laser-photobleached a second time, these microchambers gradually regained fluorescence up to the original level in the presence of 100 μM Ca^2+^, but not in the presence of 100 μM Ca^2+^ plus 1.0 μM EGCg or tannic acid ([Fig. 3*C*](#fig03){ref-type="fig"} and [Fig. S11](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)), indicating that phospholipid scrambling by TMEM16F could be triggered more than one time in our microarrays.

Kinetic Analysis of TMEM16F-Mediated Phospholipid Scrambling. {#s6}
-------------------------------------------------------------

Although the percentage of microchambers with scramblase activity increased as the area of the bilayer membrane increased ([Fig. 3*E*](#fig03){ref-type="fig"}), the scrambling process also slowed down ([Fig. 4*A*](#fig04){ref-type="fig"}). Because TMEM16F-mediated scrambling is reversible ([@r5]), the reaction should follow$$\left\lbrack {Lipid_{\text{out}}} \right\rbrack\underset{k}{\overset{k}{\rightleftarrows}}\left\lbrack {Lipid_{\text{in}}} \right\rbrack,$$where *k* is the rate constant and \[*Lipid*~out~\] and \[*Lipid*~in~\] are the concentrations of fluorescent lipids at the outer and inner layers, respectively. Notably, \[*Lipid*~out~\] is considered constant because it is contiguous with a large lipid monolayer in surrounding areas. Since the fluorescent intensity over the microchamber (*FI*) is proportional to the concentration of fluorescent lipids, *FI* is thus determined as a function of time *t*;$$FI = FI_{\text{out}} + FI_{\text{in}} \cdot \left\lbrack {1 - \exp\left( {- k^{\ast} \cdot \, t} \right)} \right\rbrack,$$$$k^{\ast} = \frac{k}{\eta} \cdot \frac{1}{S},$$where *FI*~out~ and *FI*~in~ are the fluorescent intensities of the outer and inner layers, respectively; *S* is the area of the membrane over the microchambers; and *η* is the number of lipid molecules per unit area of the monolayer (∼2.0 × 10^6^ per square micron), as determined previously ([@r32]). Fitting the time course in [Fig. 4*A*](#fig04){ref-type="fig"} to [Eq. **1**](#eq1){ref-type="disp-formula"} demonstrated *k*\*, the rate constant of fluorescent increase at 25 °C. As expected from [Eq. **2**](#eq2){ref-type="disp-formula"}, *k*\* was inversely proportional to *S* ([Fig. 4*B*](#fig04){ref-type="fig"}), demonstrating that *k*, the rate of TMEM16F-mediated lipid transport, was 4.5 × 10^4^ lipids per second at 25 °C ([Fig. 4*C*](#fig04){ref-type="fig"}); this value was ∼10^8^-fold faster than spontaneous vertical lipid flip-flop across membrane bilayers ([@r28]). Importantly, the *k* value did not differ between fluorescence substrates (i.e., TopFluor-TMR-PS, TopFluor-TMR-PC, and TopFluor-TMR-PE; [Fig. 4*C*](#fig04){ref-type="fig"}), indicating that TMEM16F did not distinguish between head group moieties of phospholipids and confirming that TMEM16F nonspecifically scrambled phospholipids. In addition, the *k* value did not differ at different lipid compositions \[e.g., in the absence or presence of phosphatidylinositol (PI); [Fig. 4*C*](#fig04){ref-type="fig"}\], suggesting that the lipid composition did not significantly affect the scrambling activity of TMEM16F.

![Biophysical characterization of TMEM16F-mediated scrambling. (*A*) Area (*S*) of the bilayer membrane was calculated (*Top*) from 3D confocal fluorescence images (*Middle*). (Scale bar: 2.5 μm.) (*Bottom*) Microarrays with membrane bilayers of the indicated areas were loaded with (red) or without (gray) 3.4 μg/mL TMEM16F in a buffer containing 100 μM CaCl~2~, and TopFluor-TMR-PS was followed for the indicated times. Experiments were repeated 24--166 times, and average values from 389 to 20,280 microchambers are plotted with SDs. Black curves are fits to the single-exponential function y = C~1~ + C~2~ × (1 − exp\[−*k* × (t − 1,000)\]). AU, arbitrary unit; d, diameter of chamber. (*B*) Rate constant of fluorescence increase (*k*\*) of TopFluor-TMR-PS was plotted against the inverse of membrane area (1/*S*). Data are from at least 380 microchambers in 16 independent experiments, and average values are shown as red circles with SDs. The black line is a linear regression. (*C*) Values of *k* determined at various lipid compositions: 0.3 mg/mL POPC with 0.001 mg/mL TopFluor-TMR-PS (red), TopFluor-TMR-PC (light red), or TopFluor-TMR-PE (pink); 0.24 mg/mL POPC; 0.03 mg/mL POPS; and 0.03 mg/mL liver PI with 0.001 mg/mL TopFluor-TMR-PS (orange).](pnas.1717956115fig04){#fig04}

TMEM16F-mediated scrambling was temperature-dependent ([Fig. 5*A*](#fig05){ref-type="fig"} and [Fig. S12](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)), with *k* values of 1.4 × 10^4^ and 7.1 × 10^4^ lipids per second at 16 °C and 35 °C, respectively. The corresponding Arrhenius plot fit well to a linear function ([Fig. 5*B*](#fig05){ref-type="fig"}), indicating that TMEM16F-mediated lipid transport was governed by a single rate-limiting step, at least from 16 to 31 °C. The thermodynamic parameters of this rate-limiting step were as follows: ΔG^‡^ = 47 kJ/mol, ΔH^‡^ = 82 kJ/mol, and TΔS^‡^ = 35 kJ/mol at 25 °C ([Fig. 5*B*](#fig05){ref-type="fig"}, *Inset*). The ΔG^‡^ value for spontaneous vertical lipid flip-flop was ∼100 kJ/mol ([@r28]), suggesting that TMEM16F significantly reduces the activation free energy.

![Temperature dependence of TMEM16F-mediated scrambling. (*A*) Rate constant of fluorescence increase (*k*\*) represented by orange, red, and blue circles was plotted against the inverse of the membrane area (1/*S*). Data in blue, red, and orange were obtained using TopFluor-TMR-PS at 16 °C, 25 °C, and 31 °C, respectively. Black lines are linear regressions. (*B*) Arrhenius plot for TMEM16F-mediated phospholipid scrambling, with *k* values from *A* (purple). The solid line represents linear regression. (*Inset*) Thermodynamic parameters at 25 °C, as determined from the plot.](pnas.1717956115fig05){#fig05}

Discussion {#s7}
==========

In this study, we demonstrated the single-molecule analysis of phospholipid scrambling of TMEM16F. The rate of phospholipid transport by a single molecule of TMEM16F was estimated as *k* = 4.5 × 10^4^ lipids per second at 25 °C (i.e., 2.2 × 10^−5^ s was required to translocate a single phospholipid across the membrane bilayer). Compared with other membrane transporters, the rate of phospholipid transport by TMEM16F was faster than those of carrier proteins, such as F-type ([@r16]) and P-type ([@r33]) ATPases (\<10^2^ molecules per second), and similar to those of channel proteins, such as KirBac1.1 ([@r34]) (\>10^5^ molecules per second). Carrier proteins transport substrates by coupling with conformational changes fueled by enzymatic reactions, for example, ATP hydrolysis, which is presumably a rate-limiting step of transport activity ([@r35], [@r36]). In contrast, channel proteins form a transmembrane pore (conducting pathway), allowing substrates to diffuse very rapidly ([@r34], [@r37]). Thus, the rate of phospholipid transport by TMEM16F was reasonable because TMEM16F-mediated scrambling did not require any energy input (i.e., a diffusion-limiting process). These findings supported the idea that, similar to ligand-gated channels ([@r38]), TMEM16F provided a cleft (conducting pathway) for phospholipid diffusion upon Ca^2+^ binding ([@r10], [@r12]).

To estimate the diffusion properties, we constructed a simple physical model of phospholipid scrambling of TMEM16F: 1D diffusion of phospholipids across the cleft of TMEM16F. The time required for phospholipids to travel across the membranes was written as *t* = λ^2^/*D*, where λ and *D* are the thickness of the membrane bilayer (∼4 nm) and the diffusion coefficient of the phospholipid, respectively. From this equation, we obtained a *D* value as 0.7 μm^2^⋅s^−1^ in the cleft of TMEM16F; this value was similar to that of lateral diffusion in membrane bilayers (i.e., 1.0 μm^2^⋅s^−1^) ([@r27]) ([Fig. S4](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)). Thus, TMEM16F may scramble phospholipids in a manner similar to lateral diffusion in membrane bilayers.

Recent computational and biochemical studies have proposed a stepping-stone model for TMEM16F-mediated phospholipid scrambling ([@r10], [@r12]). In this model, phospholipids bind to positively charged residues located on the transmembrane segment of TMEM16F (stepping stones) via electrostatic interactions with the phosphate moiety of the head group and move stepwise through the membrane bilayers. We found that the head group moieties of phospholipids (i.e., PS, PC, PE) did not affect the scramblase activity of TMEM16F, supporting that only the phosphate moiety forming an electrostatic interaction played an important role for scrambling of phospholipids in the stepping-stone model. The formation of electrostatic interactions induced a negative entropy change, and its disruption induced a positive entropy change. The increase in entropy (TΔS^‡^) by 35 kJ/mol in the scrambling reaction ([Fig. 5*B*](#fig05){ref-type="fig"}) implied that phospholipid transport may be rate-limited by the release of lipid molecules from stepping stones in TMEM16F.

In this study, we fabricated a microarray with more than 10,000 microchambers lidded by asymmetrical membrane bilayers and measured phospholipid scrambling by a single TMEM16F molecule. The microarray will enable more detailed investigation of this process and will expand the versatility of scramblase assays to other TMEM16 proteins ([@r7]), some of which are localized to the endoplasmic reticulum and could not be analyzed by cell-based assays. In addition, the device developed in this study will be useful to measure the phospholipid-translocation activity of other membrane proteins, such as caspase-dependent scramblases, floppases, and flippases, at the single-molecule level ([@r39], [@r40]). Finally, mammalian membrane proteins are often difficult to produce at a large scale. Here, by repeating fluorescence-activated cell sorting (FACS) with mAbs that recognized the extracellular region of TMEM16F, we established a cell line overexpressing TMEM16F and developed a convenient purification procedure. This procedure could have applications in the purification of other membrane proteins.

Materials and Methods {#s8}
=====================

Materials. {#s9}
----------

Alexa Fluor dyes 405, 488, and 555 were purchased from Thermo Fisher Scientific. POPC and 1-palmitoyl-2-oleoyl-*sn*-glycero-3-phospho-[l]{.smallcaps}-serine (POPS) were purchased from NOF Co., and bovine liver PI, TopFluor-TMR-PS, TopFluor-TMR-PC, and TopFluor-TMR-PE were from Avanti Polar Lipid. EGCg and tannic acid were purchased from Nacalai Tesque and Wako Chemicals, respectively.

Fabrication of Microchamber Arrays. {#s10}
-----------------------------------

CYTOP (Asahi-Glass) was coated on a glass cover slide (32 mm × 24 mm; Matsunami) by using the spin-coater (MS-B100, Mikasa) at 4,000 rpm for 30 s and baked for 1 h at 180 °C. The thickness of the CYTOP layer was 0.5 μm. Photolithography was then performed using a positive photoresist (AZP4903; AZ Electronic Materials) to pattern-mask structures on the CYTOP layer. Subsequently, the resist-patterned substrate was dry-etched with O~2~ plasma using a reactive ion etching system (RIE-10NR; Samco) to expose an array of hydrophilic SiO~2~ glass. Finally, the substrate was cleaned and rinsed with acetone and isopropyl alcohol to remove the photoresist layer. The fabrication success rate was 100%. [Fig. 2](#fig02){ref-type="fig"} and [Fig. S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental) illustrate the design of the fabricated microchamber array.

Formation of Lipid Membrane. {#s11}
----------------------------

The flow cell (∼10 μL) was constructed by assembling a glass slide with microchambers, a spacer sheet (Frame-Seal; BIO-RAD), and a glass block with a sample injection port (length/width/height = 20 mm/20 mm/5 mm) ([Fig. S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1717956115/-/DCSupplemental)). The microchambers were first filled with 10 μL of buffer A \[4 mM Tris⋅HCl buffer (pH 7.5), 30 mM NaCl\] containing fluorescent dyes (20 μM Alexa Fluor 405 or 1 μM Alexa Fluor 488). Then, 10 μL of chloroform solution containing phospholipids (0.3 mg⋅mL^−1^ POPC with 1.0 mg⋅mL^−1^ TopFluor-TMR-PS, TopFluor-TMR-PC, or TopFluor-TMR-PE; 0.24 mg⋅mL^−1^ POPC; 0.03 mg⋅mL^−1^ POPS; and 0.03 mg⋅mL^−1^ liver PI with 1.0 mg⋅mL^−1^ TopFluor-TMR-PS) was then infused into the flow cell via the access port. Finally, 190 μL of buffer B \[2 mM Tris⋅HCl buffer (pH 7.5), 15 mM NaCl\] was infused to form lipid membranes.

Imaging. {#s12}
--------

Fluorescent time-lapse recordings for passive transport and phospholipid scramblase assays were acquired under a confocal microscope system fitted with photomultiplier tubes and a 60× objective lens (A1R; Nikon). Alexa Fluor 405 and Alexa Fluor 488 were excited at 405 nm and 488 nm, respectively, and phospholipids labeled with TopFluor-TMR were excited at 561 nm. Fluorescent intensities were analyzed in NIS Elements (Nikon). Single-molecule detection of fluorescently labeled TMEM16F was performed under a TIRFM (IX71; Olympus) microscope equipped with an electron-multiplying CCD (iXon; Andor) and a 60× objective lens (N.A. = 1.49; Olympus). The Flag-TMEM16F was labeled with anti-Flag Alexa Fluor 555 and excited at 532 nm. The laser power at the optical inlet of the microscope was 5.7 mW. Fluorescent intensity was analyzed by ImageJ (NIH).

Fluorescence Recovery. {#s13}
----------------------

To measure fluorescence recovery after photobleaching, the microchambers and flow cell were first filled with buffer A containing 20 μM Alexa Fluor 405, followed by buffer B. The labeled phospholipids were then photobleached for a few seconds at λ = 561 nm, using a laser-scanning confocal microscope (A1R; Nikon). To assay scramblase activity, bilayer membranes were formed, photobleached as described above, and loaded with TMEM16F for 30 min. Scrambling was initiated by injecting buffer B containing CaCl~2~, and fluorescence images were recorded at 200-s intervals. Some reactions were performed in the presence of EGCg or tannic acid as indicated.

Passive Transport Assay. {#s14}
------------------------

The microchambers and flow cell were first filled with buffer A containing 1 μM Alexa Fluor 488 and buffer B, respectively. After the lipid membrane was formed, buffer B containing 0.5 μg/mL α-hemolysin (HT101; Toxin Co.) was injected into the flow cell, and fluorescence images were recorded at 30-s intervals.

Single-Molecule Fluorophore Assay. {#s15}
----------------------------------

The microchambers and flow cell were first filled with buffer A and buffer B, respectively. After lipid membrane formation, buffer B containing 3.4 μg/mL TMEM16F was injected into the flow cell. After 30 min, buffer B was injected to flush the residual TMEM16F molecules and buffer C \[10 mM Tris⋅HCl buffer (pH 7.5), 75 mM NaCl\] was injected to apply osmotic pressure for depressing the bilayer membranes onto the bottom surface of microchambers, allowing visualization of fluorophores with TIRFM ([@r41]). Next, buffer C containing 20 μg/mL anti-Flag Alexa Fluor 555 was injected to conjugate Alexa Fluor 555--TMEM16F complex. After 10 min, buffer C was injected to flash the residual anti-Flag Alexa Fluor 555. Fluorescence images were recorded at 30 frames per second.
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